PMID: 6970297Nov 17, 1980Paper

Follow-up study on antibody dependent cell-mediated cytotoxicity and cell-mediated cytotoxicity to HBs-antigen conjugated target cells in patients with hepatitis B (author's transl)

Klinische Wochenschrift
H WarnatzR Werntges

Abstract

Results of a follow up study on ADCC and CMC to HBs antigen conjugated target cells in patients with hepatitis B are given. The cytotoxic reaction was measured immediately after onset of the disease, three weeks and three months thereafter CMC was increased over the whole observation period. The results in hepatitis B patients were significantly different to those in normal controls. The ADCC in the presence of an antiserum to HBs antigen was in patients with hepatitis B immediately after onset of the disease reduced in comparison to the controls; it increased during the three months to the values of the controls in patients with uncomplicated disease. Experiments with isolated lymphocyte populations showed that the ADCC is mainly dependent on Fc receptor bearing lymphocytes whereas the CMC is mediated by T-cells and Fc-receptor bearing cells.

References

Apr 15, 1975·International Journal of Cancer. Journal International Du Cancer·M Jondal, H Pross
Apr 1, 1974·Clinical Immunology and Immunopathology·R J DeHoratiusR C Williams
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·C E Mogensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.